Cargando…
Factors associated with initiation and persistence of urate-lowering therapy
BACKGROUND: Gout is the most common inflammatory arthritic disease and is caused by crystal deposition secondary to persistent hyperuricemia. Etiological treatment with urate-lowering therapy (ULT) has been available since the 1950s but previous studies have demonstrated suboptimal degree of treatme...
Autores principales: | Dehlin, Mats, Ekström, Emin Hoxha, Petzold, Max, Strömberg, Ulf, Telg, Gunilla, Jacobsson, Lennart T. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240247/ https://www.ncbi.nlm.nih.gov/pubmed/28095891 http://dx.doi.org/10.1186/s13075-016-1211-y |
Ejemplares similares
-
Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy
por: Drivelegka, Panagiota, et al.
Publicado: (2018) -
Correction to: Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy
por: Drivelegka, Panagiota, et al.
Publicado: (2018) -
Impact of psoriasis disease activity and other risk factors on serum urate levels in patients with psoriasis and psoriatic arthritis—a post-hoc analysis of pooled data from three phase 3 trials with secukinumab
por: Dehlin, Mats, et al.
Publicado: (2021) -
Association between serum level of urate and subclinical atherosclerosis: results from the SCAPIS Pilot
por: Drivelegka, Panagiota, et al.
Publicado: (2020) -
Association between perinatal factors and future risk for gout—a nested case-control study
por: Dehlin, Mats, et al.
Publicado: (2022)